Phase 1 Polycystic Ovary Syndrome Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists
Polycystic Ovary Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)100 enrolled1 locationNCT03049462
Recruiting
Phase 1
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS
Polycystic Ovary SyndromePCOSPolycystic Ovary Syndrome (PCOS)
The Foundation for Orthopaedics and Regenerative Medicine20 enrolled2 locationsNCT06143527
Recruiting
Phase 1Phase 2
Efficacy of Mazdutide for Treating PCOS
Polycystic Ovary Syndrome
Shanghai Zhongshan Hospital50 enrolled1 locationNCT06519656